MDS

Planting a tree can be a wonderful and lasting way to honor a survivor or a loved one who has passed.

In our lives before cancer, we have several avenues for our energy including family, work, school, volunteer work and on and on. We were able to juggle it all. But after a diagnosis, we need to choose one or two passions and let the rest go.

People may tell me that I look good, but I don't always feel that way.

Recovery from cancer doesn’t just involve physical health; it often involves overcoming the financial barriers between illness and wellness that make moving forward seem impossible.

Tavalisse (fostamatinib) was granted approval by the Food and Drug Administration (FDA) for patients with chronic immune thrombocytopenia (ITP) after they had an insufficiencent response to another therapy.

Patients with cancer are often asked when they’ll be done with chemotherapy or treatment. Those of us with blood cancers and bone marrow type of cancers such as aplastic anemia, myelodysplastic syndrome, lymphoma and leukemia, along with a host of other cancers sadly have to say, “never.”

Our lives are broken up after a loss, but eventually the pieces are put back together. The hard part is that the new pieces can make a totally different picture.

Sometimes a kind gesture can mean the world to someone going through a tough time.

I feel like the Giving Tree. I like to give, but some of my energy and ability to assist were taken away, not by a boy, but by a disease with consequences.

In the movie, Charlie Brown was asked what his New Year’s resolution was. With typical candor, he answered that instead of dreading the whole year he was dreading only one day at a time.

Patients with blood cancers are at an increased risk for multiple hospital readmissions. However, multidisciplinary teams and patients can work together to identify predictors and avoid these occurrences.

Through its Centers of Excellence program, the MDS Foundation helps patients get appointments with leading experts from around the world.

When it comes to cancer research, the Internet can be used for good or bad.

I certainly am not like some people who try to present the perfect façade of their lives, but I do not want to be a downer, either.

Patients aged 75 years or older diagnosed with hematologic malignancies appear significantly underrepresented in clinical trials submitted to the U.S. Food and Drug Administration (FDA), according to a retrospective analysis.

The famous philosopher Nietzsche once said, “He who has a why to live can bear almost any how.”

While recent advances in hematology are exciting, they open the door to more questions.

Prevyis (letermovir) was granted approval by the Food and Drug Administration (FDA) to prevent cytomegalovirus (CMV) infection in adult CMV-seropositive patients treated with an allogeneic hematopoietic stem cell transplant (HSCT). The result is based on a significant reduction in CMV infection rates in a phase 3 study.

A cancer survivor talks about the importance of hope, inspired by her reading of Viktor Frankl's Man's Search for Meaning, which analyzes the psychological strength of Holocaust survivors.

A cancer survivor describes all the wonderful people she has met on her arduous journey and what they mean to her.

Sometimes we can be regarded as being obsessed with cancer, but every single cancer survivor is more than that, and hold important roles in our lives to play.

Cancer survivors generally work very hard to be healthy after a diagnosis. This article gives permission to enjoy life and have a balanced attitude toward healthy living.

How one cancer survivor attempts to cope with the reality of having chemo for the rest of her life.

Injured DNA can hide damaged blood cells in myelodysplastic syndrome (MDS).

Chemo fog, or chemo brain, is a very real phenomena that cancer survivors need to be knowledgeable about. This describes the journey of one survivor.

CURE spoke with Rami S. Komrokji, M.D. about collaborative efforts that will lead to new advances in the treatment of myelodysplastic syndrome (MDS).

In an interview with CURE, Rami Komrokji, M.D., a hematologist at Moffitt Cancer Center in Tampa, Florida, discusses the advances that have been made in MDS in the past few years, as well as the MDS Clinical Research Consortium and its importance.

MDS is a rare form of cancer with its own unique characteristics. Here is one patients perspective on the experience of having MDS.

An intensive preparatory stem cell transplant (SCT) regimen should be used for younger patients with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS), according to the results of a phase 3 clinical trial.